Trial intelligence / Profile preview

Desflurane Preconditioning in Liver Surgery

NCT03848780Completed

Sponsor
Aristotle University of Thessaloniki
Start
Apr 2016
Primary completion
Jun 2018
Modality
Allosteric Modulators
01

Overview

Randomised, double-blind trial of desflurane in ischemia-reperfusion injury (IRI) (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoints: Matrix Metalloproteinase 2, Matrix Metalloproteinase 9 and 2 more. Started Apr 2016; status: completed.

02

Drugs

desflurane
03

Conditions

ischemia-reperfusion injury (IRI)

Beyond the preview

Go deeper on NCT03848780.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03848780.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call